| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
major histocompatibility complex, class I, B | 0.379 | 0.885 | 3.9E-05 |
|
phenotype | 0.100 | None | 1.000 | 2 | 60 | 2009 | 2015 | ||||||||
|
psoriasis susceptibility 1 candidate 1 | 0.656 | 0.731 | 2.7E-04 |
|
phenotype | 0.100 | None | 1.000 | 2 | 53 | 2009 | 2010 | ||||||||
|
corneodesmosin | 0.585 | 0.731 | 0.46 |
|
phenotype | 0.100 | None | 1.000 | 2 | 32 | 2009 | 2010 | ||||||||
|
long intergenic non-protein coding RNA 243 | 0.729 | 0.423 |
|
phenotype | 0.100 | None | 1.000 | 2 | 20 | 2009 | 2010 | |||||||||
|
long intergenic non-protein coding RNA 2571 | 0.743 | 0.500 |
|
phenotype | 0.100 | None | 1.000 | 2 | 17 | 2009 | 2010 | |||||||||
|
tenascin XB | 0.572 | 0.731 | 1.9E-02 |
|
phenotype | 0.100 | None | 1.000 | 2 | 11 | 2009 | 2010 | ||||||||
|
HLA complex P5 | 0.595 | 0.808 |
|
phenotype | 0.100 | None | 1.000 | 2 | 7 | 2009 | 2010 | |||||||||
|
major histocompatibility complex, class II, DO beta | 0.705 | 0.500 | 1.9E-06 |
|
phenotype | 0.100 | None | 1.000 | 1 | 6 | 2009 | 2009 | ||||||||
|
USP8 pseudogene 1 | 0.805 | 0.269 |
|
phenotype | 0.100 | None | 1.000 | 1 | 6 | 2010 | 2010 | |||||||||
|
MHC class I polypeptide-related sequence B | 0.576 | 0.731 | 4.1E-05 |
|
phenotype | 0.100 | None | 1.000 | 2 | 5 | 2009 | 2010 | ||||||||
|
coiled-coil alpha-helical rod protein 1 | 0.505 | 0.808 | 1.0E-16 |
|
phenotype | 0.100 | None | 1.000 | 2 | 5 | 2009 | 2010 | ||||||||
|
MHC class I polypeptide-related sequence A | 0.473 | 0.846 | 5.0E-03 |
|
phenotype | 0.100 | None | 1.000 | 2 | 5 | 2009 | 2015 | ||||||||
|
mucin 22 | 0.729 | 0.500 | 1.4E-02 |
|
phenotype | 0.100 | None | 1.000 | 2 | 5 | 2009 | 2010 | ||||||||
|
proline rich coiled-coil 2A | 0.656 | 0.654 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 1 | 5 | 2010 | 2010 | ||||||||
|
zinc ribbon domain containing 1 antisense, pseudogene | 0.691 | 0.538 |
|
phenotype | 0.100 | None | 1.000 | 1 | 5 | 2009 | 2009 | |||||||||
|
transporter 2, ATP binding cassette subfamily B member | 0.517 | 0.808 | 6.9E-11 |
|
phenotype | 0.100 | None | 1.000 | 1 | 5 | 2009 | 2009 | ||||||||
|
discoidin domain receptor tyrosine kinase 1 | 0.497 | 0.808 | 4.6E-06 |
|
phenotype | 0.100 | None | 1.000 | 2 | 4 | 2009 | 2010 | ||||||||
|
TSBP1 and BTNL2 antisense RNA 1 | 0.638 | 0.692 |
|
phenotype | 0.100 | None | 1.000 | 2 | 4 | 2009 | 2010 | |||||||||
|
cytochrome P450 family 21 subfamily A member 2 | 0.525 | 0.769 | 2.6E-04 |
|
phenotype | 0.100 | None | 1.000 | 2 | 4 | 2009 | 2010 | ||||||||
|
HLA complex group 27 | 0.805 | 0.346 | 2.3E-02 |
|
phenotype | 0.100 | None | 1.000 | 2 | 4 | 2009 | 2010 | ||||||||
|
allograft inflammatory factor 1 | 0.521 | 0.808 | 1.9E-06 |
|
phenotype | 0.100 | None | 1.000 | 1 | 4 | 2010 | 2010 | ||||||||
|
ring finger protein 39 | 0.760 | 0.538 | 2.0E-05 |
|
phenotype | 0.100 | None | 1.000 | 1 | 4 | 2009 | 2009 | ||||||||
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
phenotype | 0.100 | None | 1.000 | 2 | 3 | 2009 | 2010 | ||||||||
|
ATP6V1G2-DDX39B readthrough (NMD candidate) | 0.769 | 0.423 |
|
phenotype | 0.100 | None | 1.000 | 2 | 3 | 2009 | 2010 | |||||||||
|
DExD-box helicase 39B | 0.641 | 0.808 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 2 | 3 | 2009 | 2010 |